MedTrace Logo

The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy

NCT04516590 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2020-08-18

No results posted yet for this study

Summary

multi-central and prospectively study the diagnostic value of autoimmune antibody detection in new and chronic epilepsy, and provide reference for clinical practice

Conditions

Interventions

OTHER

There was no intervention in this observational study

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    collaborator OTHER

  • LanZhou University

    collaborator OTHER

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • Wulumuqi General Hospital of Lanzhou Military Command

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • Xiangya Hospital of Central South University

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Affiliated Hospital of Qinghai University

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-31
Primary Completion
2021-09-30
Completion
2021-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04516590 on ClinicalTrials.gov